PDS0101 Met Criteria for Expansion to Phase 2 Trial Following Positive Results
PDS Biotechnology Corporation announced positive results from Stage 1 of a National Cancer Institute (NCI)-led clinical trial for PDS01ADC,...
PDS Biotechnology Corporation announced positive results from Stage 1 of a National Cancer Institute (NCI)-led clinical trial for PDS01ADC,...
Artelo Biosciences announced preclinical data for its CBD-TMP cocrystal drug, ART12.11, at the International Cannabinoid Research Society Symposium. The...
Jasper Therapeutics has reported updated data from its BEACON Phase 1b/2a study of briquilimab, a subcutaneous antibody therapy for...
Cogent Biosciences announced positive top-line results from its SUMMIT clinical trial of bezuclastinib for non-advanced systemic mastocytosis (NonAdvSM). The...
A recent study published in •Med• revealed that Plinabulin, in combination with radiation and PD-1 inhibitors, shows promise in...
Ashvattha Therapeutics announced interim Phase 2 trial results for its subcutaneous migaldendranib (MGB), a potential treatment for diabetic macular...
Chemomab Therapeutics announced positive Phase 2 SPRING trial data for nebokitug (CM-101) in patients with primary sclerosing cholangitis (PSC)...
Corbus Pharmaceuticals has initiated the multiple ascending dose (MAD) portion of its Phase 1 trial for CRB-913, an obesity...
Assembly Biosciences has dosed the first participant in a Phase 1b study of ABI-1179, an oral, long-acting herpes simplex...
Stereotaxis announced the publication of initial clinical results for its MAGiC robotic magnetic navigation ablation catheter in the Journal...